Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD

被引:148
作者
Sipponen, Taina [1 ]
Nuutinen, Hannu [1 ]
Turunen, Ulla [1 ]
Farkkila, Martti [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Div Gastroenterol, Dept Med, Helsinki 00029, Finland
关键词
CDEIS; Crohn's disease; endoscopic activity; endoscopic monitoring; SES-CD; FECAL CALPROTECTIN; CLINICAL-TRIALS; ACTIVITY INDEX; END-POINTS; INFLIXIMAB; THERAPY; SCORE; LACTOFERRIN; VALIDATION; ADULTS;
D O I
10.1002/ibd.21300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Few data exist of prospective parallel scoring of the validated endoscopic scores in Crohn's disease (CD), Crohn's Disease Index of Severity (CDEIS), and Simple Endoscopic Score for Crohn's Disease (SES-CD). Methods: Both the CDEIS and the SES-D were scored immediately after each endoscopy of 86 CD patients referred for ileocolonoscopy in a cross-sectional study. Furthermore, after CD therapy, 32 CD patients underwent a follow-up endoscopy with scoring of the CDEIS and SES-CD. Endoscopic scorings were graded as inactive, mild, moderate, or severe. Clinical activity was assessed with the Crohn's Disease Activity Index (CDAI) and serum C-reactive protein (CRP) was measured. Results: The SES-CD correlated with the CDEIS significantly (Spearman's r = 0.938, P < 0.0001). Weaker correlations were detected between the SES-CD and the CDAI (r = 0.473) or CRP (r = 0.525, both P < 0.0001). Grading of SES-CD from inactive to severe correlated significantly with grading of the CDEIS (r = 0.859, P < 0.0001). Changes between baseline and follow-up endoscopy scores correlated significantly (r = 0.828 between delta-CDEIS and delta-SES-CD, P < 0.001), but failed to correlate with delta-CDAI or delta-CRP (all P > 0.05). Conclusions: Both validated endoscopic scores, the CDEIS and SES-CD, and their changes during CD therapy demonstrated a close correlation. For scoring of endoscopic activity in clinical routine, the SES-CD could replace the CDEIS.
引用
收藏
页码:2131 / 2136
页数:6
相关论文
共 20 条
[1]   Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease [J].
Baert, Filip ;
Moortgat, Liesbeth ;
Van Assche, Gert ;
Caenepeel, Philip ;
Vergauwe, Philippe ;
De Vos, Martine ;
Stokkers, Pieter ;
Hommes, Daniel ;
Rutgeerts, Paul ;
Vermeire, Severine ;
D'Haens, Geert .
GASTROENTEROLOGY, 2010, 138 (02) :463-468
[2]  
BEST WR, 1976, GASTROENTEROLOGY, V70, P439
[3]   Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].
D'Haens, G ;
Van Deventer, S ;
Van Hogezand, R ;
Chalmers, D ;
Kothe, C ;
Baert, F ;
Braakman, T ;
Schaible, T ;
Geboes, K ;
Rutgeerts, P .
GASTROENTEROLOGY, 1999, 116 (05) :1029-1034
[4]   Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial [J].
D'Haens, Geert ;
Baert, Filip ;
van Assche, Gert ;
Caenepeel, Philip ;
Vergauwe, Philippe ;
Tuynman, Hans ;
De Vos, Martine ;
van Deventer, Sander ;
Stitt, Larry ;
Donner, Allan ;
Vermeire, Severine ;
Van De Mierop, Frank J. ;
Coche, Jean-Charles R. ;
van der Woude, Janneke ;
Ochsenkuehn, Thomas ;
van Bodegraven, Ad A. ;
van Hootegem, Philippe P. ;
Lambrecht, Guy L. ;
Mana, Fazia ;
Rutgeerts, Paul ;
Feagan, Brian G. ;
Hommes, Daniel .
LANCET, 2008, 371 (9613) :660-667
[5]   Endpoints for Clinical Trials Evaluating Disease Modification and Structural Damage in Adults with Crohn's Disease [J].
D'Haens, Geert R. ;
Fedorak, Richard ;
Lemann, Marc ;
Feagan, Brian G. ;
Kamm, Michael A. ;
Cosnes, Jacques ;
Rutgeerts, Paul J. ;
Marteau, Philippe ;
Travis, Simon ;
Schoelmerich, Juergen ;
Hanauer, Steven ;
Sandborn, William J. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (10) :1599-1604
[6]   Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD [J].
Daperno, M ;
D'Haens, G ;
Van Assche, G ;
Baert, F ;
Bulois, P ;
Maunoury, V ;
Sostegni, R ;
Rocca, R ;
Pera, A ;
Gevers, A ;
Mary, JY ;
Colombel, JF ;
Rutgeerts, P .
GASTROINTESTINAL ENDOSCOPY, 2004, 60 (04) :505-512
[7]   Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease [J].
Geboes, K ;
Rutgeerts, P ;
Opdenakker, G ;
Olson, A ;
Patel, K ;
Wagner, CL ;
Marano, CW .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (11) :1741-1754
[8]  
Mary J, 2005, GUT S7, V54, pA50
[9]   DEVELOPMENT AND VALIDATION OF AN ENDOSCOPIC INDEX OF THE SEVERITY FOR CROHNS-DISEASE - A PROSPECTIVE MULTICENTER STUDY [J].
MARY, JY ;
MODIGLIANI, R .
GUT, 1989, 30 (07) :983-989
[10]   CLINICAL, BIOLOGICAL, AND ENDOSCOPIC PICTURE OF ATTACKS OF CROHNS-DISEASE - EVOLUTION ON PREDNISOLONE [J].
MODIGLIANI, R ;
MARY, JY ;
SIMON, JF ;
CORTOT, A ;
SOULE, JC ;
GENDRE, JP ;
RENE, E .
GASTROENTEROLOGY, 1990, 98 (04) :811-818